查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1596117

免疫测量市场：按类型、产品类型、应用、最终用户划分 - 全球预测 2025-2030

Radioimmunoassays Market by Type (Coated-Tube RIA, Double-Antibody RIA), Product Type (Analyzers, Reagents & Kits), Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年免疫测量市值为4.4894亿美元，预计2024年将达4.6861亿美元，复合年增长率为4.52%，到2030年将达到6.12亿美元。

免疫测量(RIA) 提供了一种使用放射性标记物质测量抗原和荷尔蒙水平的先进技术，在临床和研究环境中发挥重要作用。 RIA的需求在于其灵敏、特异性的诊断能力，主要应用于免疫学、肿瘤学、内分泌学和药理学。 RIA 在致力于阐明荷尔蒙功能、诊断慢性疾病和发现新药物的实验室中发挥重要作用。 RIA 的最终用途包括医院、诊断中心和研究机构，以及製药和生物技术公司，其中精确和准确的生物标记检测至关重要。 RIA 市场受到慢性病盛行率上升、个人化医疗需求不断增长以及精准诊断进步的显着影响。然而，市场也面临挑战，例如与放射性标记物质相关的高成本、严格的监管指南以及向 ELISA 等非放射性替代品的缓慢转变。儘管有这些限制，技术创新正在创造新的机会，包括提高检测过程的自动化程度以及开发有潜力扩大 RIA 应用范围的混合检测。公司可以透过投资研发来利用这些机会，以克服小型化检测和降低放射性暴露风险等限制。此外，扩大与学术机构的合作和伙伴关係可以为新型生物标记研究铺平道路。最大限度地降低试剂成本并改善 RIA 製程的环保方面对于维持市场成长至关重要。儘管 RIA 市场呈现温和成长，但对个人化医疗和生物技术领域的技术创新和开拓应用的开拓的关注预计将带来显着的业务成长。传统方法和新的数位替代方案之间的市场是动态的，对新型检测技术的持续适应和策略投资对于持续成功至关重要。

主要市场统计
基准年[2023] 44894万美元
预测年份 [2024] 46861万美元
预测年份 [2030] 6.12 亿美元
复合年增长率（%） 4.52%

市场动态：揭示快速发展的放射免疫测量市场的关键市场洞察

供需的动态交互作用正在改变放射免疫测量市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 慢性病和感染疾病的盛行率
    • 世界各地诊断影像中心不断增加
    • 快速转向早期诊断和医疗保健支出飙升
  • 市场限制因素
    • 对保存期限短和放射性物质危险的担忧
  • 市场机会
    • 政府对生命科学研究活动的资助快速增加
    • 整合先进技术进行疾病诊断
  • 市场问题
    • 替代免疫检测的存在和缺乏熟练的专业人员

波特五力：驾驭放射免疫测量市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解免疫测量市场的外部影响

外部宏观环境因素在塑造免疫测量市场的表现动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助企业预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析：了解免疫测量市场的竞争格局

免疫测量市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵：免疫测量市场供应商绩效评估

FPNV定位矩阵是评估免疫测量市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：绘製放射免疫测量市场的成功之路

免疫测量市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1.市场渗透率：对当前市场环境的详细审查，主要企业的广泛资料，评估他们在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 慢性病及感染疾病率增加
      • 世界各地的诊断影像中心不断增加
      • 快速转向早期诊断和飙升的医疗费用
    • 抑制因素
      • 对放射性物质保存期限短及相关风险的担忧
    • 机会
      • 政府对生命科学研究活动的资助快速增加
      • 整合先进技术进行疾病诊断
    • 任务
      • 存在替代的先进免疫检测方法且缺乏熟练的专业人员
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章免疫测量市场：依类型

  • 介绍
  • 涂层管RIA
  • 双抗体放射免疫分析

第七章免疫测量市场：依产品类型

  • 介绍
  • 分析仪
  • 试剂和套件

第八章免疫测量市场：依应用分类

  • 介绍
  • 临床诊断
  • 研究

第九章免疫测量市场：依最终用户分类

  • 介绍
  • 学术研究所
  • 临床诊断实验室
  • 医院
  • 製药和 CRO

第十章美洲免疫测量市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太放射免疫测量市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲免疫测量市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abbexa Limited
  • Abcam Plc
  • ALPCO
  • Antigenix America, Inc.
  • Berthold Technologies GmbH & Co.KG
  • Biosynth Ltd
  • BioVendor-Laboratorni medicina as
  • Creative Biomart, Inc.
  • Danaher Corporation
  • Demeditec Diagnostics GmbH
  • Diasorine SPA
  • DRG International, Inc. by BioCheck Inc.
  • Drive DeVilbiss International
  • EUROIMMUN Medizinische Labordiagnostika AG
  • Hidex Oy.
  • IBL International GmbH
  • Immuno-Biological Laboratories, Inc.
  • Institute of Isotopes Co. Ltd.
  • LKB Instruments
  • LubioScience GmbH
  • Marin Biologic Laboratories, Inc.
  • Merck & Co, Inc
  • Montreal BIoTech Inc.
  • MP Biomedicals, LLC
  • NovoLytix GmbH
  • Padyab Teb Co.
  • PerkinElmer Inc.
Product Code: MRR-C002B1C99627

The Radioimmunoassays Market was valued at USD 448.94 million in 2023, expected to reach USD 468.61 million in 2024, and is projected to grow at a CAGR of 4.52%, to USD 612.00 million by 2030.

Radioimmunoassays (RIA) offer a sophisticated technique for measuring antigens and hormone levels through the use of radiolabeled substances, playing a crucial role in both clinical and research settings. The necessity of RIAs lies in their highly sensitive and specific diagnostic capability, applicable mostly in immunology, oncology, endocrinology, and pharmacology. RIAs serve an essential function in laboratories focused on understanding hormone functions, diagnosing chronic diseases, and discovering new drugs. The end-use scope of RIAs encompasses hospitals, diagnostic centers, and research institutions, as well as pharmaceutical and biotechnology companies where precise and accurate biomarker detection is critical. The market for RIAs is significantly influenced by the rising prevalence of chronic diseases, growing demand for personalized medicine, and advancements in precision diagnostics. However, the market also faces challenges such as the high cost associated with radio-labeled substances, stringent regulatory guidelines, and the gradual shift toward non-radioactive alternatives like ELISA. Despite these constraints, new opportunities emerge with technological innovations, such as enhanced automation in assay processes and development of hybrid assays that can potentially expand the reach of RIAs. Companies can leverage these opportunities by investing in R&D to overcome limitations, such as assay miniaturization and the reduction of radioactive exposure risks. Additionally, expanding collaborations or partnerships with academic institutions can open pathways for novel biomarker research. It is crucial to minimize reagent costs and improve the eco-friendly aspects of RIA processes to sustain market growth. While the RIA market shows moderate growth, the focus on innovation and exploration of untapped applications in personalized medicine and biotechnology sectors can offer substantial business growth. The market remains dynamically poised between traditional methods and emerging digital alternatives, making continuous adaptation and strategic investments in novel assay technologies imperative for sustained success.

KEY MARKET STATISTICS
Base Year [2023] USD 448.94 million
Estimated Year [2024] USD 468.61 million
Forecast Year [2030] USD 612.00 million
CAGR (%) 4.52%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Radioimmunoassays Market

The Radioimmunoassays Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing prevalence of chronic and infectious disease
    • Increasing number of imaging centers across the globe
    • Rapid shift towards early diagnosis and surge in healthcare expenditure
  • Market Restraints
    • Short shelf life and associated hazards concern with radioactive materials
  • Market Opportunities
    • Surge in government funding for life science research activity
    • Integration of advanced technology for disease diagnostics
  • Market Challenges
    • Presence of alternative advanced immunoassays and the dearth of skilled professionals

Porter's Five Forces: A Strategic Tool for Navigating the Radioimmunoassays Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Radioimmunoassays Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Radioimmunoassays Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Radioimmunoassays Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Radioimmunoassays Market

A detailed market share analysis in the Radioimmunoassays Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Radioimmunoassays Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Radioimmunoassays Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Radioimmunoassays Market

A strategic analysis of the Radioimmunoassays Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Radioimmunoassays Market, highlighting leading vendors and their innovative profiles. These include Abbexa Limited, Abcam Plc, ALPCO, Antigenix America, Inc., Berthold Technologies GmbH & Co.KG, Biosynth Ltd, BioVendor - Laboratorni medicina a.s., Creative Biomart, Inc., Danaher Corporation, Demeditec Diagnostics GmbH, Diasorine S.P.A., DRG International, Inc. by BioCheck Inc., Drive DeVilbiss International, EUROIMMUN Medizinische Labordiagnostika AG, Hidex Oy., IBL International GmbH, Immuno-Biological Laboratories, Inc., Institute of Isotopes Co. Ltd., LKB Instruments, LubioScience GmbH, Marin Biologic Laboratories, Inc., Merck & Co, Inc, Montreal Biotech Inc., MP Biomedicals, LLC, NovoLytix GmbH, Padyab Teb Co., and PerkinElmer Inc..

Market Segmentation & Coverage

This research report categorizes the Radioimmunoassays Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Coated-Tube RIA and Double-Antibody RIA.
  • Based on Product Type, market is studied across Analyzers and Reagents & Kits.
  • Based on Application, market is studied across Clinical Diagnostics and Research.
  • Based on End-User, market is studied across Academic & Research Institutes, Clinical Diagnostic Laboratories, Hospitals, and Pharmaceuticals & CROs.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of chronic and infectious disease
      • 5.1.1.2. Increasing number of imaging centers across the globe
      • 5.1.1.3. Rapid shift towards early diagnosis and surge in healthcare expenditure
    • 5.1.2. Restraints
      • 5.1.2.1. Short shelf life and associated hazards concern with radioactive materials
    • 5.1.3. Opportunities
      • 5.1.3.1. Surge in government funding for life science research activity
      • 5.1.3.2. Integration of advanced technology for disease diagnostics
    • 5.1.4. Challenges
      • 5.1.4.1. Presence of alternative advanced immunoassays and the dearth of skilled professionals
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Radioimmunoassays Market, by Type

  • 6.1. Introduction
  • 6.2. Coated-Tube RIA
  • 6.3. Double-Antibody RIA

7. Radioimmunoassays Market, by Product Type

  • 7.1. Introduction
  • 7.2. Analyzers
  • 7.3. Reagents & Kits

8. Radioimmunoassays Market, by Application

  • 8.1. Introduction
  • 8.2. Clinical Diagnostics
  • 8.3. Research

9. Radioimmunoassays Market, by End-User

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
  • 9.3. Clinical Diagnostic Laboratories
  • 9.4. Hospitals
  • 9.5. Pharmaceuticals & CROs

10. Americas Radioimmunoassays Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Radioimmunoassays Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Radioimmunoassays Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbexa Limited
  • 2. Abcam Plc
  • 3. ALPCO
  • 4. Antigenix America, Inc.
  • 5. Berthold Technologies GmbH & Co.KG
  • 6. Biosynth Ltd
  • 7. BioVendor - Laboratorni medicina a.s.
  • 8. Creative Biomart, Inc.
  • 9. Danaher Corporation
  • 10. Demeditec Diagnostics GmbH
  • 11. Diasorine S.P.A.
  • 12. DRG International, Inc. by BioCheck Inc.
  • 13. Drive DeVilbiss International
  • 14. EUROIMMUN Medizinische Labordiagnostika AG
  • 15. Hidex Oy.
  • 16. IBL International GmbH
  • 17. Immuno-Biological Laboratories, Inc.
  • 18. Institute of Isotopes Co. Ltd.
  • 19. LKB Instruments
  • 20. LubioScience GmbH
  • 21. Marin Biologic Laboratories, Inc.
  • 22. Merck & Co, Inc
  • 23. Montreal Biotech Inc.
  • 24. MP Biomedicals, LLC
  • 25. NovoLytix GmbH
  • 26. Padyab Teb Co.
  • 27. PerkinElmer Inc.

LIST OF FIGURES

  • FIGURE 1. RADIOIMMUNOASSAYS MARKET RESEARCH PROCESS
  • FIGURE 2. RADIOIMMUNOASSAYS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS RADIOIMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS RADIOIMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES RADIOIMMUNOASSAYS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES RADIOIMMUNOASSAYS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC RADIOIMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC RADIOIMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. RADIOIMMUNOASSAYS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. RADIOIMMUNOASSAYS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. RADIOIMMUNOASSAYS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. RADIOIMMUNOASSAYS MARKET DYNAMICS
  • TABLE 7. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY COATED-TUBE RIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY DOUBLE-ANTIBODY RIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY PHARMACEUTICALS & CROS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS RADIOIMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES RADIOIMMUNOASSAYS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC RADIOIMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. RADIOIMMUNOASSAYS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 190. RADIOIMMUNOASSAYS MARKET, FPNV POSITIONING MATRIX, 2023